On Target Laboratories
On Target Laboratories innovates in developing and commercializing cell-targeting molecules for various cancers.
Founded
2010On Target Laboratories innovates in developing and commercializing cell-targeting molecules for various cancers.
On Target Laboratories, founded in West Lafayette, United States, is dedicated to discovering, developing, and commercializing small molecules that target specific pathological cells when conjugated with fluorescent dyes. The company's core mission is to enhance the precision of cancer surgeries by making cancer cells more visible to surgeons. Their products focus on targeting various cancers, including lung, uterine, kidney, breast, colon, pancreatic, and prostate cancers.
Notable affiliated individuals include key researchers and scientists specializing in oncology and molecular imaging. The company has secured investments from prominent venture capital firms and has achieved significant milestones in clinical trials, demonstrating the efficacy of their fluorescent dye conjugates in improving surgical outcomes. On Target Laboratories' innovative approach has the potential to significantly impact cancer treatment by reducing the likelihood of residual cancer cells post-surgery.
Companies similar to On Target Laboratories include Inherent Targeting, Vergent Bioscience, Lumicell and OncoTartis.
On Target Laboratories was founded in 2010.
On Target Laboratories' headquarters is located in Northbrook, IL, US.
On Target Laboratories' most recent funding round was for $30M (USD) in November 2023.
As of Nov 16, 2023, On Target Laboratories has disclosed funding of $111.7M (USD). Undisclosed round amounts are excluded.
On Target Laboratories has 75 employees as of Feb 4, 2024.
OncoTartis
